On October 27, 2023, Helix BioPharma Corp. closed the transaction. In connection with the closing, the company paid a cash fee of 10% of gross proceeds raised to an eligible finder.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.21 CAD | 0.00% | +20.00% | 0.00% |
Apr. 08 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
Mar. 28 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 35.2M | |
+2.62% | 42.75B | |
+47.70% | 41.61B | |
+12.01% | 41.34B | |
-8.83% | 26.59B | |
+7.72% | 25.49B | |
-22.68% | 18.12B | |
+30.90% | 12.24B | |
-1.75% | 11.76B | |
+9.55% | 11B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it has received CAD 2.998 million in funding